Scinovex
review Open AccessTop 1% cited

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly

European Journal of Endocrinology · 2008 · Vol. 159(2) · pp. 89–95
I.M. HoldawayMark J BollandG. Gamble

Abstract

Clinicians treating acromegalic patients should aim for random serum GH <2.5 microg/l measured by RIA (probably <1 microg/l measured by modern sensitive immunoassay) and normal serum IGF-I values, to restore the elevated mortality of the condition to normal levels.

Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsOphthalmology and Eye DisordersAcromegalyMedicineInternal medicineConfidence intervalMeta-analysisStandardized mortality ratioEndocrinologySomatostatinEndocrine systemGastroenterology

MeSH terms

AcromegalyCause of DeathFollow-Up StudiesHumansInsulin-Like Growth Factor IRemission InductionGrowth HormoneDown-Regulation
Citations
458
FWCI
11.59
field-weighted impact
References
28
Percentile
99%
vs. same field & year
Citations per year
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
The Journal of Clinical Endocrinology & Metabolism · 2012 · 1,439 citations
Acromegaly: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism · 2014 · 1,747 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.